Positive margins matter regardless of subsequent resection findings

• Published in: Oral oncology Vol. 128; p. 105850
• Main Authors: Coutu, Brendan, Ryan, Evan, Christensen, Dallin, Lawrence, Elliot, Bell, Elizabeth Bradford, Zhen, Weining, Sayed, Zafar
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2022
• Subjects: Adjuvant management; Carcinoma, Squamous Cell - pathology; Head and neck; Head and Neck Neoplasms; Humans; Margin; Margins of Excision; Mouth Neoplasms - pathology; Neoplasm Recurrence, Local - pathology; Oral cavity squamous cell carcinoma; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck - surgery; Adjuvant management; Head and neck; Oral cavity squamous cell carcinoma; Margin
• ISSN: 1368-8375; 1879-0593
• DOI: 10.1016/j.oraloncology.2022.105850

•A high rate of patients with oral cavity cancer were found to have an intraoperative positive margin.•Most patients with an intraoperative positive margin were able to undergo further resection to yield a final negative margin.•Regardless of final margin status, patients with intraoperative positive margin were found to have worse outcomes. In the resection of oral cavity squamous cell carcinoma (OCSCC), an intraoperative positive surgical margin (SM) communicated to the head and neck surgeon necessitates further resection of the area of identified involvement to achieve a final negative SM. The prognostic implication of initial positive SM when the final SM is negative is understudied. We retrospectively reviewed 249 patients with non-metastatic (stage I–IVB) OCSCC who underwent a resection from 2010 to 2019 to assess the prognostic impact of an initial positive SM. Chi-squared analysis was used to evaluate the association between an initial positive SM and clinicopathologic parameters. A Kaplan–Meier analysis was performed to estimate patient outcomes with Cox regression analysis used to determine absolute hazards. At a median follow-up of 28.4 months, the 2-year freedom from local recurrence (FFLR), disease-free survival (DFS), and overall survival (OS) rates were 82.1%, 63.5%, and 78.5%, respectively. Fifty patients (20.1%) had an initial positive SM which was revised to a negative SM on frozen and permanent sections by resecting further tissue while 12 patients (4.8%) had a final positive SM. An initial positive SM was independently associated with a worse FFLR (HR: 2.696, p = 0.004), DFS (HR: 1.57, p = 0.044), and OS (HR: 1.72, p = 0.029). An initial positive SM is independently associated with worse disease control and patient survival. A positive SM may be a surrogate for diffusely infiltrative disease as further malignancy identified on the re-resection specimen was associated with worse outcomes.